On Nov 12, major Wall Street analysts update their ratings for $Nevro (NVRO.US)$, with price targets ranging from $6 to $9.
Morgan Stanley analyst Kallum Titchmarsh maintains with a hold rating, and maintains the target price at $9.
Baird analyst David Rescott maintains with a hold rating, and adjusts the target price from $11 to $6.
RBC Capital analyst Shagun Singh Chadha maintains with a hold rating, and maintains the target price at $7.
CCORF analyst William Plovanic maintains with a hold rating, and adjusts the target price from $17 to $7.
JMP Securities analyst David Turkaly maintains with a hold rating.
Furthermore, according to the comprehensive report, the opinions of $Nevro (NVRO.US)$'s main analysts recently are as follows:
The firm maintains a position of cautious observation, noting that the ongoing business transformation at Nevro continues to be a central narrative. Despite reporting third quarter revenues and EBITDA that exceeded Central Nervous System projections, revenues still fall short of the full-year expectations for the previous year, with clear indicators of stabilization or growth acceleration yet to be seen.
Here are the latest investment ratings and price targets for $Nevro (NVRO.US)$ from 5 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
